GERMANY SAYS IT WON’T BE BUYING RUSSIAN OIL AT ALL IN 2023

Soleno Therapeutics, Inc. announced it will receive $59.89 Million in funding from Abingworth LLP, Vivo Capital, LLC, Nantahala Capital Management, LLC, Brightleaf Capital, Corbin Capital Partners, L.P.